As partial deletion of ROCK1 or ROCK2 has been found to attenuate high-fat-diet obesity-induced insulin resistance [81,82], the use of Y27632 in patients suffering from obesity could be a strategy to decrease AdEV release and reduce cardiovascular diseases associated with obesity [83]. Here, ROCK1 is linked to obesity disorder.